Translumina Logo

Translumina GmbH

Coronary Drug-Eluting Stents

Translumina GmbH was established in 2000 and since then has developed into a leading company in the production and development of innovative and biocompatible coronary Catheter- and Stent Systems. The drug-eluting stents Yukon Choice PC and Yukon Chrome PC have been tested in long-term clinical studies and the products are recommended from leading cardiological societies. Since 2019 Translumina GmbH Germany is working successfully together with the Indian partner company Translumina Therapeutics under the new international name Translumina - Limitless Possibilities.

Category Medical technology
Working areas Biomaterials, Development, Healthcare, Trade/Distribution, Medical products
Year of foundation